The Role of B-Vitamins in Bone Health and Disease in Older Adults

Current Osteoporosis Reports

Volumn 13, Issue 4, 2015, Pages 256-261

  Bailey, Regan L ^a,b   van Wijngaarden, Janneke P ^c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b PURDUE UNIVERSITY   (United States)

^c Nutricia Nederland   (Netherlands)

Author keywords

B vitamins; Bone fracture; Bone mineral density; Homocysteine

Indexed keywords

VITAMIN B COMPLEX;

AGED; BONE; BONE DENSITY; FRACTURES, BONE; HUMAN; METABOLISM; MIDDLE AGED; OSTEOPOROSIS; PHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BONE AND BONES; BONE DENSITY; FRACTURES, BONE; HUMANS; MIDDLE AGED; OSTEOPOROSIS; VITAMIN B COMPLEX;

EID: 84934435316     PISSN: 15441873     EISSN: 15442241     Source Type: Journal    
DOI: 10.1007/s11914-015-0273-0     Document Type: Review

References (61)

1. National Institute of Arthritis and Musculoskeletal and Skin Diseases. NIH Osteoporosis and Related Bone Diseases National Resource Center. 2014 September 3, 2014]; Available from: http://www.niams.nih.gov/Health_Info/Bone/Osteoporosis/osteoporosis_ff.asp.
2. Lips P, van Schoor NM. Quality of life in patients with osteoporosis. Osteoporos Int. 2005;16(5):447–55.
3. van Wijngaarden JP et al. Vitamin B12, folate, homocysteine, and bone health in adults and elderly people: a systematic review with meta-analyses. J Nutr Metab. 2013;2013:486186.
4. Miller JW et al. Metabolic evidence of vitamin B-12 deficiency, including high homocysteine and methylmalonic acid and low holotranscobalamin, is more pronounced in older adults with elevated plasma folate. Am J Clin Nutr. 2009;90(6):1586–92.
5. Miller JW et al. Effect of vitamin B-6 deficiency on fasting plasma homocysteine concentrations. Am J Clin Nutr. 1992;55(6):1154–60.
6. Pfeiffer CM et al. Estimation of trends in serum and RBC folate in the U.S. population from pre- to postfortification using assay-adjusted data from the NHANES 1988–2010. J Nutr. 2012;142(5):886–93.
7. Pennypacker LC et al. High prevalence of cobalamin deficiency in elderly outpatients. J Am Geriatr Soc. 1992;40(12):1197–204.
8. Green R, Miller JW. Vitamin B12 deficiency is the dominant nutritional cause of hyperhomocysteinemia in a folic acid-fortified population. Clin Chem Lab Med. 2005;43(10):1048–51.
9. Carmel R. Biomarkers of cobalamin (vitamin B-12) status in the epidemiologic setting: a critical overview of context, applications, and performance characteristics of cobalamin, methylmalonic acid, and holotranscobalamin II. Am J Clin Nutr. 2011;94(1):348S–58.
10. Herrmann M et al. The effect of B-vitamins on biochemical bone turnover markers and bone mineral density in osteoporotic patients: a 1-year double blind placebo controlled trial. Clin Chem Lab Med. 2007;45(12):1785–92.
11. Herrmann M et al. Folate supplementation does not affect biochemical markers of bone turnover. Clin Lab. 2006;52(3-4):131–6.
12. Herrmann, W., et al., One year B and D vitamins supplementation improves metabolic bone markers. Clin Chem Lab Med, 2012: p. 1-9.
13. Shahab-Ferdows S et al. Vitamin B-12 supplementation of rural Mexican women changes biochemical vitamin B-12 status indicators but does not affect hematology or a bone turnover marker. J Nutr. 2012;142(10):1881–7.
14. Eastell R, Hannon RA. Biomarkers of bone health and osteoporosis risk. Proc Nutr Soc. 2008;67(2):157–62.
15. Keser, I., et al., Folic acid and vitamin B12 supplementation lowers plasma homocysteine but has no effect on serum bone turnover markers in elderly women: a randomized, double-blind, placebo-controlled trial. Nutrition Research, 2013.
16. Sato Y et al. Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA. 2005;293(9):1082–8.
17. van Wijngaarden JP et al. Rationale and design of the B-PROOF study, a randomized controlled trial on the effect of supplemental intake of vitamin B12 and folic acid on fracture incidence. BMC Geriatr. 2011;11:80.
18. van Wijngaarden JP et al. Effect of daily vitamin B-12 and folic acid supplementation on fracture incidence in elderly individuals with an elevated plasma homocysteine concentration: B-PROOF, a randomized controlled trial. Am J Clin Nutr. 2014;100(6):1578–86.
19. Sawka AM et al. Randomized clinical trial of homocysteine level lowering therapy and fractures. Arch Intern Med. 2007;167(19):2136–9.
20. Gommans J et al. The effect of homocysteine-lowering with B-vitamins on osteoporotic fractures in patients with cerebrovascular disease: substudy of VITATOPS, a randomised placebo-controlled trial. BMC Geriatr. 2013;13:88.
21. Leboff MS et al. Homocysteine levels and risk of hip fracture in postmenopausal women. J Clin Endocrinol Metab. 2009;94(4):1207–13.
22. Gerdhem P et al. Associations between homocysteine, bone turnover, BMD, mortality, and fracture risk in elderly women. J Bone Miner Res. 2007;22(1):127–34.
23. Dhonukshe-Rutten RAM et al. Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people. J Bone Miner Res. 2005;20(6):921–9.
24. Gjesdal CG et al. Plasma homocysteine, folate, and vitamin B 12 and the risk of hip fracture: the Hordaland homocysteine study. J Bone Miner Res. 2007;22(5):747–56.
25. van Meurs JB et al. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med. 2004;350(20):2033–41.
26. McLean RR et al. Plasma B vitamins, homocysteine, and their relation with bone loss and hip fracture in elderly men and women. J Clin Endocrinol Metab. 2008;93(6):2206–12.
27. McLean RR et al. Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med. 2004;350(20):2042–9.
28. Yang J et al. Homocysteine level and risk of fracture: a meta-analysis and systematic review. Bone. 2012;51(3):376–82.
29. Vaes BL et al. Vitamin B(12) deficiency stimulates osteoclastogenesis via increased homocysteine and methylmalonic acid. Calcif Tissue Int. 2009;84(5):413–22.
30. Saito M, Fujii K, Marumo K. Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in cases of hip fracture and controls. Calcif Tissue Int. 2006;79(3):160–8.
31. Gjesdal CG et al. Plasma total homocysteine level and bone mineral density: the Hordaland homocysteine study. Arch Intern Med. 2006;166(1):88–94.
32. Ouzzif Z et al. Relation of plasma total homocysteine, folate and vitamin B12 levels to bone mineral density in Moroccan healthy postmenopausal women. Rheumatol Int. 2012;32(1):123–8.
33. Enneman AW et al. The association between plasma homocysteine levels and bone quality and bone mineral density parameters in older persons. Bone. 2014;63:141–6.
34. Bozkurt N et al. The relationship of homocyteine, B12 and folic acid with the bone mineral density of the femur and lumbar spine in Turkish postmenopausal women. Arch Gynecol Obstet. 2009;280(3):381–7.
35. Refsum H et al. The Hordaland homocysteine study: a community-based study of homocysteine, its determinants, and associations with disease. J Nutr. 2006;136(6):1731S–40.
36. Mittal A, Sathian B. Elevated homocysteine level is a potential risk factor for osteoporosis among elderly population of Nepal. Clin Chem Lab Med. 2012;50(2):A52.
37. Herrmann M, Widmann T, Herrmann W. Homocysteine—a newly recognised risk factor for osteoporosis. Clin Chem Lab Med. 2005;43(10):1111–7.
38. Rumbak I et al. Bone mineral density is not associated with homocysteine level, folate and vitamin B12 status. Arch Gynecol Obstet. 2012;285(4):991–1000.
39. Ravaglia G et al. Folate, but not homocysteine, predicts the risk of fracture in elderly persons. J Gerontol A Biol Sci Med Sci. 2005;60(11):1458–62.
40. Holstein JH et al. Hyperhomocysteinemia is not associated with reduced bone quality in humans with hip osteoarthritis. Clin Chem Lab Med. 2010;48(6):821–7.
41. Mudd SH et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet. 1985;37(1):1–31.
42. Morris MS, Jacques PF, Selhub J. Relation between homocysteine and B-vitamin status indicators and bone mineral density in older Americans. Bone. 2005;37(2):234–42.
43. Zhu K et al. The effects of homocysteine and MTHFR genotype on hip bone loss and fracture risk in elderly women. Osteoporos Int. 2009;20(7):1183–91.
44. Cagnacci A et al. Relation of folates, vitamin B12 and homocysteine to vertebral bone mineral density change in postmenopausal women. A five-year longitudinal evaluation. Bone. 2008;42(2):314–20.
45. Cagnacci A et al. Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women. Bone. 2003;33(6):956–9.
46. Krivosikova Z et al. The association between high plasma homocysteine levels and lower bone mineral density in Slovak women: the impact of vegetarian diet. Eur J Nutr. 2010;49(3):147–53.
47. Naharci I et al. Vitamin B12 and folic acid levels as therapeutic target in preserving bone mineral density (BMD) of older men. Arch Gerontol Geriatr. 2012;54(3):469–72.
48. Dhonukshe-Rutten RAM et al. Vitamin B-12 status is associated with bone mineral content and bone mineral density in frail elderly women but not in men. J Nutr. 2003;133(3):801–7.
49. Tucker KL et al. Low plasma vitamin B12 is associated with lower BMD: the Framingham osteoporosis study. J Bone Miner Res. 2005;20(1):152–8.
50. Stone KL et al. Low serum vitamin B-12 levels are associated with increased hip bone loss in older women: a prospective study. J Clin Endocrinol Metab. 2004;89(3):1217–21.
51. Haliloglu B et al. Relationship between bone mineral density, bone turnover markers and homocysteine, folate and vitamin B12 levels in postmenopausal women. Arch Gynecol Obstet. 2010;281(4):663–8.
52. Lewerin C et al. Low holotranscobalamin and cobalamins predict incident fractures in elderly men: the MrOS Sweden. Osteoporos Int. 2014;25(1):131–40.
53. Golbahar J et al. Association of plasma folate, plasma total homocysteine, but not methylenetetrahydrofolate reductase C667T polymorphism, with bone mineral density in postmenopausal Iranian women: a cross-sectional study. Bone. 2004;35(3):760–5.
54. Bucciarelli P et al. The relationship between plasma homocysteine levels and bone mineral density in post-menopausal women. Eur J Intern Med. 2010;21(4):301–5.
55. Baines M et al. The association between cysteine, bone turnover, and low bone mass. Calcif Tissue Int. 2007;81(6):450–4.
56. Holstein JH et al. Low serum folate and vitamin B-6 are associated with an altered cancellous bone structure in humans. Am J Clin Nutr. 2009;90(5):1440–5.
57. Enneman AW et al. The association between plasma homocysteine levels, methylation capacity and incident osteoporotic fractures. Bone. 2012;50(6):1401–5.
58. Tane N et al. Effect of vitamin B6 deficiency on collagen metabolism in rats. J Nutr Sci Vitaminol (Tokyo). 1976;22(2):105–14.
59. Herrmann M et al. Increased osteoclast activity in the presence of increased homocysteine concentrations. Clin Chem. 2005;51(12):2348–53.
60. Kim GS et al. Effects of vitamin B12 on cell proliferation and cellular alkaline phosphatase activity in human bone marrow stromal osteoprogenitor cells and UMR106 osteoblastic cells. Metabolism. 1996;45(12):1443–6.
61. Vaes BL et al. Inhibition of methylation decreases osteoblast differentiation via a non-DNA-dependent methylation mechanism. Bone. 2010;46(2):514–23.